Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting

Gwendolyn S Kerby1, Margaret Rosenfeld, Clement L Ren

  • 1Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B395, Aurora, Colorado 80045, USA. gwendolyn.kerby@childrenscolorado.org

Pediatric Pulmonology
|November 15, 2011
PubMed

Insights

Spirometry is the most sensitive lung function test for cystic fibrosis (CF) preschoolers, though challenges remain. This study assessed lung function measures in CF children to guide future clinical trials.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Trial Methodology
  • Respiratory Physiology

Background:

  • Clinical trials in cystic fibrosis (CF) preschoolers are hindered by the lack of sensitive, multi-center lung function measures.
  • Developing reliable methods is crucial for evaluating interventions in this population.

Purpose of the Study:

  • Assess feasibility and reproducibility of spirometry, forced oscillometry (FO), and inductance plethysmography (IP) in preschool CF patients.
  • Compare the ability of these techniques to differentiate lung function between CF preschoolers and controls.
  • Evaluate longitudinal lung function changes and estimate sample sizes for future trials.

Main Methods:

  • A longitudinal, multi-center study involving 93 CF preschoolers and 87 controls.
  • Standardized equipment, rigorous site training, and centralized data review were employed.
  • CF subjects had up to four study visits (6 months apart) plus a reproducibility visit; controls had one visit.

Main Results:

  • Inductance plethysmography (IP) showed the highest acceptability (77%), while spirometry had the lowest (55%).
  • Spirometry indices (FEV(1), FEV(0.5), FEF(25-75)) were lower in CF subjects and declined with age.
  • Forced oscillometry (FO) indices did not distinguish CF from controls, but spirometry detected the smallest treatment effect.

Conclusions:

  • Spirometry is more sensitive than IP or FO for detecting lung disease in CF preschoolers, with indices declining by age.
  • Future CF trials should incorporate spirometry training and require acceptable pre-enrollment data.
  • Near-normal spirometry in preschoolers may complicate treatment effect detection.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...